SI1185529T1 - Pirazolobenzodiazepini kot inhibitorji cdk2 - Google Patents
Pirazolobenzodiazepini kot inhibitorji cdk2Info
- Publication number
- SI1185529T1 SI1185529T1 SI200030524T SI200030524T SI1185529T1 SI 1185529 T1 SI1185529 T1 SI 1185529T1 SI 200030524 T SI200030524 T SI 200030524T SI 200030524 T SI200030524 T SI 200030524T SI 1185529 T1 SI1185529 T1 SI 1185529T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyrazolobenzodiazepines
- cdk2 inhibitors
- cdk2
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/22—Sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13037099P | 1999-04-21 | 1999-04-21 | |
| PCT/EP2000/003394 WO2000064900A1 (en) | 1999-04-21 | 2000-04-14 | Pyrazolobenzodiazepines as cdk2 inhibitors |
| EP00929360A EP1185529B1 (en) | 1999-04-21 | 2000-04-14 | Pyrazolobenzodiazepines as cdk2 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1185529T1 true SI1185529T1 (sl) | 2005-02-28 |
Family
ID=22444382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200030524T SI1185529T1 (sl) | 1999-04-21 | 2000-04-14 | Pirazolobenzodiazepini kot inhibitorji cdk2 |
Country Status (33)
| Country | Link |
|---|---|
| US (3) | US6440959B1 (sl) |
| EP (1) | EP1185529B1 (sl) |
| JP (1) | JP3746680B2 (sl) |
| KR (1) | KR100481757B1 (sl) |
| CN (2) | CN1196703C (sl) |
| AR (1) | AR023542A1 (sl) |
| AT (1) | ATE279413T1 (sl) |
| AU (1) | AU768667B2 (sl) |
| BR (1) | BR0009887A (sl) |
| CA (1) | CA2367704C (sl) |
| CO (1) | CO5170444A1 (sl) |
| CZ (1) | CZ20013738A3 (sl) |
| DE (1) | DE60014893T2 (sl) |
| DK (1) | DK1185529T3 (sl) |
| ES (1) | ES2228522T3 (sl) |
| HK (1) | HK1046278B (sl) |
| HR (1) | HRP20010742A2 (sl) |
| HU (1) | HUP0300318A3 (sl) |
| IL (1) | IL145764A0 (sl) |
| JO (1) | JO2248B1 (sl) |
| MA (1) | MA26782A1 (sl) |
| NO (1) | NO20015065L (sl) |
| NZ (1) | NZ514523A (sl) |
| PE (1) | PE20010054A1 (sl) |
| PL (1) | PL200933B1 (sl) |
| PT (1) | PT1185529E (sl) |
| RU (1) | RU2249593C2 (sl) |
| SI (1) | SI1185529T1 (sl) |
| TR (1) | TR200103016T2 (sl) |
| TW (1) | TW585866B (sl) |
| WO (1) | WO2000064900A1 (sl) |
| YU (1) | YU73101A (sl) |
| ZA (1) | ZA200108016B (sl) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL370176A1 (en) * | 2001-11-13 | 2005-05-16 | 3-Dimensional Pharmaceuticals, Inc. | Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| FR2847253B1 (fr) * | 2002-11-19 | 2007-05-18 | Aventis Pharma Sa | Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant |
| BRPI0407841A (pt) * | 2003-02-27 | 2006-11-14 | Abbott Lab | inibidores heterocìclicos de quinase |
| BRPI0518152A (pt) * | 2004-10-13 | 2008-11-04 | Hoffmann La Roche | pirazolbenzodiazepinas dissubstituìdas úteis como inibidores para cdk2 e angiogênese e para o tratamento de cánceres de mama, cólon, pulmão e próstata |
| CA2624025A1 (en) * | 2005-10-14 | 2007-04-19 | F. Hoffmann-La Roche Ag | Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo [3, 4.-b] [1, 4] benzodiazepine |
| CA2657347C (en) | 2006-07-10 | 2014-11-18 | Paion Uk Limited | Short-acting benzodiazepine salts and their polymorphic forms |
| KR20100073454A (ko) * | 2008-12-23 | 2010-07-01 | 국립암센터 | 트란스글루타미나제 억제제로 사용되는 신규한 피라졸로디아제핀계 화합물, 이의 제조방법 및 이를 포함하는 조성물 |
| EP2305647A1 (en) | 2009-09-18 | 2011-04-06 | PAION UK Limited | Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process |
| EP2450039A1 (en) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosing regimen for sedation with CNS 7056 (Remimazolam) |
| UA117342C2 (uk) * | 2012-02-02 | 2018-07-25 | Сенекс Біотекнолоджи Інк. | Селективні інгібітори cdk8/cdk19 та їх застосування як протиметастатичних та хіміопрофілактичних засобів у способах лікування раку |
| CN103288830A (zh) * | 2012-02-24 | 2013-09-11 | 中国科学院大连化学物理研究所 | 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓的方法 |
| CN103288828A (zh) * | 2012-02-24 | 2013-09-11 | 中国科学院大连化学物理研究所 | 一种合成手性二氢-6H-吲哚并[2,1-c][1,4]-苯并二氮杂卓的方法 |
| CN102603743B (zh) * | 2012-02-24 | 2014-05-28 | 南京天易生物科技有限公司 | 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途 |
| AR094963A1 (es) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | Reacción de oxidación excelente en el índice de conversión |
| CN106608877B (zh) * | 2015-10-21 | 2018-11-13 | 新发药业有限公司 | 一种依鲁替尼中间体4-氨基-3-（4-苯氧基）苯基-1H-吡唑并[3,4-d]嘧啶的制备方法 |
| CN109906220A (zh) * | 2016-11-01 | 2019-06-18 | 豪夫迈·罗氏有限公司 | 用于治疗cns相关疾病的1,3-二氢-1,4-苯并二氮杂*-2-硫酮化合物 |
| WO2018108079A1 (zh) | 2016-12-13 | 2018-06-21 | 南京药捷安康生物科技有限公司 | 多激酶抑制剂化合物、其晶型及用途 |
| CN109020980B (zh) * | 2017-06-09 | 2020-11-20 | 华东师范大学 | 一类抗肿瘤作用的吡唑并嘧啶二氮*衍生物 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
| US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
| WO2020223558A1 (en) * | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
| AU2020328025A1 (en) | 2019-08-14 | 2022-03-03 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors |
| KR20220099970A (ko) | 2019-10-11 | 2022-07-14 | 인사이트 코포레이션 | Cdk2 억제제로서의 이환식 아민 |
| KR20230008792A (ko) * | 2020-05-08 | 2023-01-16 | 트랜스테라 사이언시즈 (난징), 인크. | 항종양 화합물의 합성방법 및 그 중간체 |
| WO2022113003A1 (en) | 2020-11-27 | 2022-06-02 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
| WO2022149057A1 (en) | 2021-01-05 | 2022-07-14 | Rhizen Pharmaceuticals Ag | Cdk inhibitors |
| BR112023023223A2 (pt) | 2021-05-07 | 2024-01-30 | Kymera Therapeutics Inc | Degradadores de cdk2 e usos dos mesmos |
| TW202304427A (zh) * | 2021-05-10 | 2023-02-01 | 大陸商藥捷安康(南京)科技股份有限公司 | 多激酶抑制劑的藥物組合物及其用途 |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| WO2024030399A2 (en) * | 2022-08-02 | 2024-02-08 | Lab1636, Llc | Use of a gaba-a pam for reduction of tactile hypersensitivity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE291022T1 (de) | 1996-10-02 | 2005-04-15 | Novartis Pharma Gmbh | Pyrimiderivate und verfahren zu ihrer herstellung |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
-
2000
- 2000-04-12 US US09/548,091 patent/US6440959B1/en not_active Expired - Fee Related
- 2000-04-14 DK DK00929360T patent/DK1185529T3/da active
- 2000-04-14 KR KR10-2001-7013228A patent/KR100481757B1/ko not_active IP Right Cessation
- 2000-04-14 ES ES00929360T patent/ES2228522T3/es not_active Expired - Lifetime
- 2000-04-14 PT PT00929360T patent/PT1185529E/pt unknown
- 2000-04-14 EP EP00929360A patent/EP1185529B1/en not_active Expired - Lifetime
- 2000-04-14 CZ CZ20013738A patent/CZ20013738A3/cs unknown
- 2000-04-14 AT AT00929360T patent/ATE279413T1/de active
- 2000-04-14 SI SI200030524T patent/SI1185529T1/sl unknown
- 2000-04-14 JP JP2000614252A patent/JP3746680B2/ja not_active Expired - Fee Related
- 2000-04-14 WO PCT/EP2000/003394 patent/WO2000064900A1/en active IP Right Grant
- 2000-04-14 TR TR2001/03016T patent/TR200103016T2/xx unknown
- 2000-04-14 CN CNB008065543A patent/CN1196703C/zh not_active Expired - Fee Related
- 2000-04-14 DE DE60014893T patent/DE60014893T2/de not_active Expired - Lifetime
- 2000-04-14 BR BR0009887-6A patent/BR0009887A/pt not_active IP Right Cessation
- 2000-04-14 CA CA002367704A patent/CA2367704C/en not_active Expired - Fee Related
- 2000-04-14 PL PL354405A patent/PL200933B1/pl not_active IP Right Cessation
- 2000-04-14 AU AU47480/00A patent/AU768667B2/en not_active Ceased
- 2000-04-14 YU YU73101A patent/YU73101A/sh unknown
- 2000-04-14 CN CNB2004100682242A patent/CN1279029C/zh not_active Expired - Fee Related
- 2000-04-14 HU HU0300318A patent/HUP0300318A3/hu unknown
- 2000-04-14 RU RU2001130446/04A patent/RU2249593C2/ru not_active IP Right Cessation
- 2000-04-14 NZ NZ514523A patent/NZ514523A/en unknown
- 2000-04-14 IL IL14576400A patent/IL145764A0/xx unknown
- 2000-04-17 JO JO200054A patent/JO2248B1/en active
- 2000-04-18 AR ARP000101817A patent/AR023542A1/es not_active Application Discontinuation
- 2000-04-18 CO CO00028559A patent/CO5170444A1/es not_active Application Discontinuation
- 2000-04-19 PE PE2000000370A patent/PE20010054A1/es not_active Application Discontinuation
- 2000-04-19 TW TW089107370A patent/TW585866B/zh not_active IP Right Cessation
-
2001
- 2001-09-29 ZA ZA200108016A patent/ZA200108016B/xx unknown
- 2001-10-12 HR HR20010742A patent/HRP20010742A2/hr not_active Application Discontinuation
- 2001-10-18 NO NO20015065A patent/NO20015065L/no not_active Application Discontinuation
- 2001-10-19 MA MA26368A patent/MA26782A1/fr unknown
-
2002
- 2002-04-15 US US10/122,559 patent/US6838558B2/en not_active Expired - Fee Related
- 2002-10-29 HK HK02107815.6A patent/HK1046278B/zh not_active IP Right Cessation
-
2004
- 2004-04-19 US US10/827,667 patent/US6916923B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145764A0 (en) | Pyrazolobenzodiazepines as cdk2 inhibitors | |
| IL148614A0 (en) | Pteridinones as kinase inhibitors | |
| GB9900416D0 (en) | Inhibitors | |
| SI1686119T1 (sl) | Derivati pirimidin-5-ona kot inhibitorji ldl-pla2 | |
| GB9912961D0 (en) | Metalloprotease inhibitors | |
| EG23979A (en) | Renin inhibitors | |
| PL350452A1 (en) | Dihetero-substituted metalloprotease inhibitors | |
| HK1047276A1 (zh) | 作為pde4抑制劑的四氫噻喃2，3-二氮雜萘酮類衍生物 | |
| ZA200110053B (en) | Factor via inhibitors. | |
| IL148275A0 (en) | Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors | |
| GB9924522D0 (en) | Enzyme inhibitors | |
| HK1042695A1 (zh) | 蛋白酶抑制劑 | |
| GB0030284D0 (en) | Enzyme inhibitors | |
| PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
| GB2389113B (en) | B-secretase inhibitor | |
| EP1189618A4 (en) | thrombin | |
| GB0109278D0 (en) | Enzyme inhibitors | |
| AU2002400A (en) | Telomerase inhibitors | |
| GB9929340D0 (en) | Inhibitors | |
| GB9929341D0 (en) | Inhibitors | |
| GB9917294D0 (en) | Inhibitors | |
| GB9900413D0 (en) | Inhibitors | |
| SI1181017T1 (sl) | Zaviralci metaloproteaz | |
| GB0106564D0 (en) | Enzyme inhibitors | |
| GB0109145D0 (en) | Enzyme inhibitors |